Michael Ostrowski

10PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Inna M Chen, Julia S Johansen, Susann Theile

|Jul 08, 2022
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer.

Julia E Lefler, Catherine B MarElia-Bennett, Katie A Thies

|Jun 09, 2021
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.

Shasha Yin, Liu Liu, Charles Brobbey

|Jun 12, 2019
Nanofiber-expanded human CD34+ cells heal cutaneous wounds in streptozotocin-induced diabetic mice.

Suman Kanji, Manjusri Das, Matthew Joseph

Pageof 2